InvestorEmpowering Taiwan's entrepreneurial ecosystem through technology and capital.

ABIES Capital is a Taiwan-based healthcare investment platform that focuses on biomedical startups and invites angel investors to participate in curated investment opportunities. The firm employs a hybrid strategy combining direct investments with global asset allocation.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
ABIES Capital, also known as 杉盛資本股份有限公司, is a professional asset management company based in Taipei, Taiwan, founded in 2021. The organization focuses on investing in biomedical startups aimed at improving human health and optimizing quality of life. ABIES Capital employs a long-tail investment strategy in biomedical startups, complemented by a globally diversified asset allocation approach. The firm aims to establish long-term stable returns through its investments and runs an angel investor co-investment program, inviting qualified investors to participate in selected deals.
The firm specializes in biomedical startups, utilizing a long-tail investment strategy complemented by a globally diversified asset allocation approach. ABIES Capital aims to establish long-term stable returns through its investments in healthcare and medical device sectors.
ABIES Capital provides value to its portfolio companies through expertise in healthcare startup investment, post-investment management, and access to a network of angel investors for co-investment opportunities.
ABIES Capital focuses on biomedical startups within the healthcare and biotech sectors. The firm invests at various stages, including Angel, Pre-seed, Seed, Series A, and Series B. They look for companies that aim to improve human health and quality of life.
Founders can reach out to ABIES Capital via email at abies.info@abies.com.tw. It is advisable to include a detailed pitch deck outlining the business model, market opportunity, and team background.
ABIES Capital employs a hybrid investment strategy that combines long-tail global asset allocation with direct investments in healthcare startups. This approach allows them to generate long-term stable returns while also inviting angel investors to co-invest in selected deals.
The firm primarily invests in startups located in Asia, particularly those that are involved in the healthcare and biotech sectors.
ABIES Capital offers expertise in healthcare startup investment and post-investment management. They also provide access to a network of angel investors for co-investment opportunities, enhancing the growth potential of their portfolio companies.
While specific check sizes are not disclosed, ABIES Capital invests across various stages, indicating flexibility in their investment amounts based on the startup's needs and growth stage.
Superscout Pro
Is this page right?Reviewed · How the research works